AI Medical Device Company Aillis Selected for Tokyo's "SusHi Tech Global" Growth Acceleration Program Phase 1

AI Summary (NQ-processed)

Aillis Co., Ltd., an AI medical device developer, has been selected for the first phase of Tokyo's "SusHi Tech Global" Growth Acceleration Program. This program supports startups aiming for global growth, and Aillis will leverage up to 200 million yen in funding and tailored support to accelerate the global expansion of its AI medical devices. Aillis aims to build sustainable medical infrastructure globally through the overseas deployment of Japan-originated medical AI technology.